NCT04216017View on ClinicalTrials.gov

Glenohumeral Cortisone Injection

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

May 1, 2022

Conditions
Humeral Fractures
Interventions
DRUG

kenalog

Cortisone injection into shoulder

DRUG

Lidocaine

Lidocaine injection into shoulder

Trial Locations (1)

98104

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Washington

OTHER

NCT04216017 - Glenohumeral Cortisone Injection | Biotech Hunter | Biotech Hunter